Short-Term Efficacy and Postoperative Inflammatory Cytokine Changes in Lung Cancer Treated with Da Vinci Robot-assisted Versus Video-assisted Thoracoscopic Surgery
10.3971/j.issn.1000-8578.2023.22.1144
- VernacularTitle:达芬奇机器人与电视辅助胸腔镜手术治疗肺癌短期疗效及术后炎性细胞因子变化比较
- Author:
Ziqiang HONG
1
;
Wenxi GOU
;
Yannan SHENG
;
Xiangdou BAI
;
Baiqiang CUI
;
Dacheng JIN
;
Yunjiu GOU
Author Information
1. The First Clinical Department of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
- Publication Type:Research Article
- Keywords:
Robot-assisted thoracoscopic surgery;
Video-assisted thoracoscopic surgery;
Lung cancer;
Inflammatory cytokines
- From:
Cancer Research on Prevention and Treatment
2023;50(4):378-383
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the short-term outcomes and postoperative inflammatory cytokine changes in patients with lung cancer treated with robot-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS). Methods A total of 270 patients with lung cancer treated by minimally invasive surgery were selected for the study, and the surgical procedures were selected according to the patients' economic conditions and preferences. Among them, 132 patients completed the operation through RATS, and 138 patients completed the operation through VATS. The clinical data of the two groups were compared. Results All patients successfully completed radical lung cancer surgery, and no perioperative deaths were reported. Intraoperative bleeding, postoperative drainage time, postoperative hospital stay, number of lymph nodes dissected, and number of lymph nodes dissected groups were more advantageous in the RATS group compared with the VATS group (P < 0.05). In terms of operative time, total postoperative chest drainage, and hospitalization cost, the VATS group had an advantage (P < 0.05). The postoperative levels of CRP, PCT, IL-6, IL-8, IL-10, and TNF-α increased in both groups, compared with preoperative levels, and the increases in the RATS group were lower than those in the VATS group. Conclusion RATS offers technical and short-term efficacy advantages for the treatment of lung cancer but comes with the disadvantage of high cost. Post-operative inflammatory cytokine elevation is lower in the RATS group, and inflammatory response to the organism is less severe.
